VISSIT Intracranial Stent Study for Ischemic Therapy

NCT00816166 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

125

Enrollment

INDUSTRY

Sponsor class

Conditions

Ischemic Stroke
Transient Ischemic Attack

Interventions

DEVICE: Pharos Vitesse Neurovascular Stent System (Stent implantation) + Medical therapy (Aspirin and Clopidogrel)
DRUG: Aspirin and Clopidogrel (Medical therapy)

Sponsor

Codman & Shurtleff